查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1855807

2025年全球生物假體市場報告

Bioprosthetics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，生物假體市場規模呈現強勁成長，預計將從2024年的57.2億美元成長到2025年的62.7億美元，複合年成長率達9.7%。預測期內的成長主要受以下因素驅動：心血管疾病盛行率上升、對微創手術的需求增加、老年人口成長、醫療基礎設施擴張以及組織基植入應用日益廣泛。

預計未來幾年生物假體市場規模將維持強勁成長，2029年將達到89.5億美元，複合年成長率（CAGR）為9.3%。對個人化治療方案日益成長的偏好、新興經濟體醫療保健支出的增加、醫療旅遊的蓬勃發展、先進外科手術設施的普及以及對以患者為中心的護理的日益重視，預計將成為預測期內市場成長的主要驅動力。預測期內的主要趨勢包括瓣膜設計的技術進步、組織保存方法的創新、微創植入技術的進步、生物相容性材料的開發以及再生醫學的進展。

預計未來幾年，心血管疾病盛行率的不斷上升將推動生物假體市場的擴張。心血管疾病涵蓋多種影響心臟和血管的疾病，例如冠狀動脈疾病、心臟衰竭、心律不整、先天性心臟疾病以及腦血管疾病（如中風）。心血管疾病發生率的上升部分歸因於不良飲食習慣，包括攝取過多飽和脂肪、鹽和糖等高糖食物，這些都會導致肥胖、高血壓和高膽固醇。生物假體在治療這些疾病方面發揮著重要作用，它透過生物相容性植入替換受損的心臟瓣膜和血管，從而改善心臟功能並降低併發症的風險。例如，美國心臟協會在2024年1月報告稱，心血管相關死亡人數將從2022年的928,741人略微增加到2023年的931,578人。心血管疾病盛行率的上升是推動生物假體市場成長的關鍵因素。

生物假體市場的主要公司正致力於開發先進的組織技術。這些技術包括對生物假體材料進行特殊處理，以抑制鈣化並提高其長期功能。例如，2022年9月，美國醫療設備製造商愛德華生命科學公司（Edwards Lifesciences）的SAPIEN 3 Ultra RESILIA瓣膜獲得FDA核准。該瓣膜採用RESILIA組織技術，其中包括經抗鈣化技術處理的牛心包組織，以提高其耐用性。 SAPIEN 3 Ultra RESILIA瓣膜採用低輪廓輸送系統，旨在簡化植入過程並提高手術精度。它也是美國唯一乾式儲存經導管心臟瓣膜，具有操作簡便、瓣膜結構可劣化長達五年的優勢，可能延長臨床效益。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球生物假體：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球生物假體市場：成長率分析
  • 全球生物假體市場表現：規模與成長，2019-2024年
  • 全球生物假體市場預測：規模與成長，2024-2029年，2034年
  • 全球生物假體：潛在市場規模 (TAM)

第6章 市場細分

  • 全球生物假體市場按類型、表現和預測分類，2019-2024年、2024-2029年、2034年
  • 同種異體移植
  • 異質骨移植
  • 自體移植
  • 全球生物假體市場按應用、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 心血管系統
  • 整形外科
  • 創傷治療
  • 其他用途
  • 全球生物假體市場依最終使用者、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 醫院
  • 專業中心
  • 其他最終用戶
  • 全球生物假體市場：依同種異體移植類型、表現與預測細分，2019-2024年、2024-2029年、2034年
  • 軟骨移植
  • 肌腱移植
  • 半月軟骨
  • 植牙
  • 皮膚移植
  • 全球生物假體市場：細分異質骨移植（異種移植），按類型、表現和預測（2019-2024年、2024-2029年、2034年）
  • 豬心臟瓣膜異質骨移植
  • 牛心臟瓣膜異質骨移植
  • 豬真皮異質骨移植
  • 牛異質骨移植
  • 全球生物假體市場：依自體移植、類型、表現和預測細分，2019-2024年、2024-2029年、2034年
  • 骨移植
  • 肌腱自體移植
  • 皮膚移植
  • 自體軟骨移植

第7章 區域和國家分析

  • 全球生物假體市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
  • 全球生物假體市場：國家、績效及預測，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 生物假體市場：競爭格局
  • 生物假體市場：公司概況
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Meril Life Sciences Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • LivaNova PLC
  • Artivion Inc.
  • LifeNet Health Inc.
  • TTK Healthcare Limited
  • Corcym Srl
  • Biosensors International Group Ltd.
  • Braile Biomedica
  • Xeltis NV
  • Peijia Medical Technology Co. Ltd.
  • Labcor Laboratorios Ltda.
  • Colibri Heart Valve LLC
  • Autotissue Berlin GmbH
  • Humacyte Inc.
  • Bioprosthetics Inc.
  • Shijiazhuang Perfect Prosthetic Manufacture Co. Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年生物假體市場：蘊藏新機會的國家
  • 2029年生物假體市場：充滿新機會的細分市場
  • 2029年生物假體市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38456

Bioprosthetics is a field of biomedical science focused on developing implants or devices made from biological materials, sometimes combined with synthetic components, to replace or support damaged or missing tissues in the body. These materials are designed to replicate the structure and function of natural tissue, ensuring compatibility with the body, lowering the risk of immune rejection, and maintaining durability and long-term performance.

The primary types of bioprosthetics are allograft, xenograft, and autograft. An allograft is a transplant of tissue or an organ taken from a donor of the same species who is genetically different from the recipient. Bioprosthetics are applied in areas such as cardiovascular care, orthopedics, wound healing, and other fields, and are utilized by end users including hospitals, specialty centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The bioprosthetics market research report is one of a series of new reports from The Business Research Company that provides bioprosthetics market statistics, including the bioprosthetics industry global market size, regional shares, competitors with the bioprosthetics market share, detailed bioprosthetics market segments, market trends, and opportunities, and any further data you may need to thrive in the bioprosthetics industry. This bioprosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioprosthetics market size has grown strongly in recent years. It will grow from $5.72 billion in 2024 to $6.27 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. Growth in the historic period was supported by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive surgeries, growth in the geriatric population, expansion of healthcare infrastructure, and greater adoption of tissue-based implants.

The bioprosthetics market size is expected to see strong growth in the next few years. It will grow to $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. Growth in the forecast period is expected to be driven by a stronger preference for personalized treatment solutions, higher healthcare spending in emerging economies, expansion of medical tourism, wider availability of advanced surgical facilities, and an increasing focus on patient-centered care. Key trends anticipated for the forecast period include technological progress in valve design, innovations in tissue preservation methods, advancements in minimally invasive implantation techniques, the development of biocompatible materials, and progress in regenerative medicine.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the bioprosthetics market in the coming years. Cardiovascular diseases encompass a range of disorders that affect the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, congenital heart defects, and cerebrovascular diseases such as stroke. The rise in cardiovascular conditions is partly attributed to poor dietary habits, including the consumption of foods high in saturated fats, salt, and sugar, which contribute to obesity, hypertension, and high cholesterol levels. Bioprosthetics play a crucial role in treating these conditions by replacing damaged heart valves or blood vessels with biologically compatible implants, thereby improving heart function and reducing the risk of complications. For example, the American Heart Association reported in January 2024 that cardiovascular-related deaths increased slightly to 931,578 in 2023, up from 928,741 in 2022. This rising incidence of cardiovascular diseases is a key factor driving the growth of the bioprosthetics market.

Key companies in the bioprosthetics market are focusing on the development of advanced tissue technologies. This technology involves specialized treatments of bioprosthetic materials to reduce calcification and improve their long-term functionality. For instance, in September 2022, Edwards Lifesciences Corporation, a U.S.-based medical device company, received FDA approval for the SAPIEN 3 Ultra RESILIA valve. This valve uses RESILIA tissue technology, which involves bovine pericardial tissue treated with anti-calcification technology to extend durability. The SAPIEN 3 Ultra RESILIA valve features a low-profile delivery system designed to simplify implantation and improve procedural precision. It is also the only dry storage transcatheter heart valve available in the U.S., offering ease of use and the potential to provide freedom from structural valve deterioration for up to five years, with the possibility of extended clinical benefits.

In July 2024, Edwards Lifesciences Corporation further expanded its structural heart portfolio by acquiring Innovalve Bio Medical Ltd., an Israel-based company specializing in bioprosthetics. The terms of the acquisition were not disclosed, but the deal is expected to accelerate product development, enhance clinical capabilities, and increase patient access to minimally invasive heart valve therapies, particularly in the field of transcatheter aortic valve replacement (TAVR).

Major players in the bioprosthetics market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., LivaNova PLC, Artivion Inc., LifeNet Health Inc., TTK Healthcare Limited, Corcym S.r.l., Biosensors International Group Ltd., Braile Biomedica, Xeltis NV, Peijia Medical Technology Co. Ltd., Labcor Laboratorios Ltda., Colibri Heart Valve LLC, Autotissue Berlin GmbH, Humacyte Inc., Bioprosthetics Inc., and Shijiazhuang Perfect Prosthetic Manufacture Co. Ltd.

North America was the largest region in the bioprosthetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioprosthetics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioprosthetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprosthetics market consists of revenues earned by entities by providing services such as custom implant design, biocompatibility testing, 3d modeling, and clinical research. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprosthetics market also includes sales of vascular grafts, cartilage repair scaffolds, bone grafts, dermal matrices, and biologic meshes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioprosthetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioprosthetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioprosthetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprosthetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Allograft; Xenograft; Autograft
  • 2) By Application: Cardiovascular; Orthopedic; Wound healing; Other Applications
  • 3) By End User: Hospitals; Specialty Centers; Other End Users
  • Subsegments:
  • 1) By Allograft: Cartilage Allograft; Tendon Allograft; Meniscus Allograft; Dental Allograft; Skin Allograft
  • 2) By Xenograft: Porcine Heart Valve Xenograft; Bovine Heart Valve Xenograft; Porcine Dermis Xenograft; Bovine Pericardium Xenograft
  • 3) By Autograft: Bone Autograft; Tendon Autograft; Skin Autograft; Cartilage Autograft
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Meril Life Sciences Pvt. Ltd.; LivaNova PLC; Artivion Inc.; LifeNet Health Inc.; TTK Healthcare Limited; Corcym S.r.l.; Biosensors International Group Ltd.; Braile Biomedica; Xeltis NV; Peijia Medical Technology Co. Ltd.; Labcor Laboratorios Ltda.; Colibri Heart Valve LLC; Autotissue Berlin GmbH; Humacyte Inc.; Bioprosthetics Inc.; Shijiazhuang Perfect Prosthetic Manufacture Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioprosthetics Market Characteristics

3. Bioprosthetics Market Trends And Strategies

4. Bioprosthetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bioprosthetics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bioprosthetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bioprosthetics Market Growth Rate Analysis
  • 5.4. Global Bioprosthetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bioprosthetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bioprosthetics Total Addressable Market (TAM)

6. Bioprosthetics Market Segmentation

  • 6.1. Global Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allograft
  • Xenograft
  • Autograft
  • 6.2. Global Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular
  • Orthopedic
  • Wound healing
  • Other Applications
  • 6.3. Global Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Centers
  • Other End Users
  • 6.4. Global Bioprosthetics Market, Sub-Segmentation Of Allograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cartilage Allograft
  • Tendon Allograft
  • Meniscus Allograft
  • Dental Allograft
  • Skin Allograft
  • 6.5. Global Bioprosthetics Market, Sub-Segmentation Of Xenograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Porcine Heart Valve Xenograft
  • Bovine Heart Valve Xenograft
  • Porcine Dermis Xenograft
  • Bovine Pericardium Xenograft
  • 6.6. Global Bioprosthetics Market, Sub-Segmentation Of Autograft, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Autograft
  • Tendon Autograft
  • Skin Autograft
  • Cartilage Autograft

7. Bioprosthetics Market Regional And Country Analysis

  • 7.1. Global Bioprosthetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bioprosthetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioprosthetics Market

  • 8.1. Asia-Pacific Bioprosthetics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioprosthetics Market

  • 9.1. China Bioprosthetics Market Overview
  • 9.2. China Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioprosthetics Market

  • 10.1. India Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioprosthetics Market

  • 11.1. Japan Bioprosthetics Market Overview
  • 11.2. Japan Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioprosthetics Market

  • 12.1. Australia Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioprosthetics Market

  • 13.1. Indonesia Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioprosthetics Market

  • 14.1. South Korea Bioprosthetics Market Overview
  • 14.2. South Korea Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioprosthetics Market

  • 15.1. Western Europe Bioprosthetics Market Overview
  • 15.2. Western Europe Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioprosthetics Market

  • 16.1. UK Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioprosthetics Market

  • 17.1. Germany Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioprosthetics Market

  • 18.1. France Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioprosthetics Market

  • 19.1. Italy Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioprosthetics Market

  • 20.1. Spain Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioprosthetics Market

  • 21.1. Eastern Europe Bioprosthetics Market Overview
  • 21.2. Eastern Europe Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioprosthetics Market

  • 22.1. Russia Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioprosthetics Market

  • 23.1. North America Bioprosthetics Market Overview
  • 23.2. North America Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioprosthetics Market

  • 24.1. USA Bioprosthetics Market Overview
  • 24.2. USA Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioprosthetics Market

  • 25.1. Canada Bioprosthetics Market Overview
  • 25.2. Canada Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioprosthetics Market

  • 26.1. South America Bioprosthetics Market Overview
  • 26.2. South America Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioprosthetics Market

  • 27.1. Brazil Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioprosthetics Market

  • 28.1. Middle East Bioprosthetics Market Overview
  • 28.2. Middle East Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioprosthetics Market

  • 29.1. Africa Bioprosthetics Market Overview
  • 29.2. Africa Bioprosthetics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bioprosthetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bioprosthetics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioprosthetics Market Competitive Landscape And Company Profiles

  • 30.1. Bioprosthetics Market Competitive Landscape
  • 30.2. Bioprosthetics Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Meril Life Sciences Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Bioprosthetics Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Artivion Inc.
  • 31.3. LifeNet Health Inc.
  • 31.4. TTK Healthcare Limited
  • 31.5. Corcym S.r.l.
  • 31.6. Biosensors International Group Ltd.
  • 31.7. Braile Biomedica
  • 31.8. Xeltis NV
  • 31.9. Peijia Medical Technology Co. Ltd.
  • 31.10. Labcor Laboratorios Ltda.
  • 31.11. Colibri Heart Valve LLC
  • 31.12. Autotissue Berlin GmbH
  • 31.13. Humacyte Inc.
  • 31.14. Bioprosthetics Inc.
  • 31.15. Shijiazhuang Perfect Prosthetic Manufacture Co. Ltd.

32. Global Bioprosthetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioprosthetics Market

34. Recent Developments In The Bioprosthetics Market

35. Bioprosthetics Market High Potential Countries, Segments and Strategies

  • 35.1 Bioprosthetics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bioprosthetics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bioprosthetics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer